In Q3 2025, Philips saw an 8% growth in comparable order intake, with group sales reaching EUR 4.3 billion and income from operations at EUR 330 million. The adjusted EBITA margin increased to 12.3%, with an operating cash flow of EUR 327 million and free cash flow of EUR 172 million. The company reiterates its full-year 2025 outlook, expecting margins at the upper end of the range.

CEO Roy Jakobs highlighted strong performance in North America driven by AI-powered innovations and long-term partnerships. Philips is focused on patient safety and quality, with the installation of the first Azurion system in East Java expanding access to minimally invasive care in Indonesia. The company remains committed to sustainability and innovation.

Innovation highlights from Philips include the launch of Lumea IPL in the US, advanced radiation therapy breakthroughs, cardiovascular ultrasound systems, and long-term partnerships with US health systems for Enterprise Monitoring as a Service. The company’s net-zero science-based target by 2045 has been validated by the Science Based Targets initiative.

Productivity initiatives at Philips delivered EUR 222 million in savings in Q3 2025, contributing to the company’s three-year EUR 2.5 billion productivity program. The company remains confident in delivering its full-year 2025 outlook, with comparable sales growth expected between 1%-3%, adjusted EBITA margin at 11.3%-11.8%, and free cash flow between EUR 0.2-0.4 billion.

Forward-looking statements from Philips address factors like geopolitical changes, tariffs, technology advancements, acquisitions, and regulatory compliance that could impact the company’s future results. The company uses non-IFRS financial measures in its reporting, with a focus on transparency and accuracy in financial reporting.

As of September 30, 2025, Philips reclassified uncertain tax liabilities, and per share calculations have been adjusted to reflect share issuances in 2025. The company continues to prioritize innovation, sustainability, and healthcare solutions for consumers and healthcare providers worldwide.

Read more at GlobeNewswire: Philips continues momentum; delivers strong order intake,